Abstract
Background: Individuals with substance use disorders (SUD), particularly opioid use disorder (OUD), who are criminal justice-involved are a particularly vulnerable population that has been adversely affected by COVID-19 due to impacts of the pandemic on both the criminal justice and treatment systems. The manuscript presents qualitative data and findings exploring issues related to SUD/OUD treatment among individuals involved in the justice system and the impacts of COVID-19 on these service systems. Qualitative data were collected separately by teams from three different research hubs/sites in Illinois, Indiana, and Kentucky; at each hub, data were collected from justice system personnel (n = 17) and community-level SUD/OUD providers (n = 21). Codes from two hubs were reviewed and merged to develop the cross-hub coding list. The combined codes were used deductively to analyze the third hub‘s data, and higher-level themes were then developed across all the hubs’ data. Results: Themes reflected the justice and treatment systems’ responses to COVID-19, the intersection of systems and COVID-19’s impact on providing OUD treatment for such individuals, and the use of telehealth and telejustice. Conclusions: Results highlight that despite rapid adaptations made by systems during the pandemic, additional work is needed to better support individuals with OUD who are involved in the justice system. Such work can inform longer-term public health crisis planning to improve community OUD treatment access and linkage for those who are criminal justice-involved.
| Original language | English |
|---|---|
| Article number | 25 |
| Journal | Health and Justice |
| Volume | 10 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 2022 |
Bibliographical note
Publisher Copyright:© 2022, The Author(s).
Funding
All three hubs’ studies were supported by the JCOIN cooperative, funded by the National Institute on Drug Abuse (NIDA) by the National Institutes of Health (NIH) through the NIH HEAL Initiative. The authors gratefully acknowledge the collaborative contributions of NIDA and support from the following grant awards: UG1DA050065 (PI: Scott), UG1DA050070 (PI: Aalsma), UG1DA050069 (PI: Staton); as well as the Indiana University Addiction Grand Challenge project ( https://grandchallenges.iu.edu/addiction/index.html ). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIDA, the NIH Heal Initiative, or the participating sites.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | UG1DA050069, UG1DA050065, UG1DA050070 |
| Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug Abuse | |
| University of Southern Indiana |
Keywords
- COVID-19
- Decarceration
- Opioid use disorder
- Substance use disorder
- Telehealth
- Telejustice
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
- Law